Combined treatment with MAO-A inhibitor and MAO-B inhibitor increases 
extracellular noradrenaline levels more than MAO-A inhibitor alone through 
increases in beta-phenylethylamine

Kitaichi, Y.; Inoue, T.; Nakagawa, S.; Boku, S.; Izumi, T.; Koyama, T.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Combined treatment with MAO-A inhibitor and MAO-B inhibitor increases extracellular noradrenaline levels more than MAO-A inhibitor alone through increases in beta-phenylethylamine

MPS-Authors

/persons/resource/persons80399

Kitaichi, Y.
AG Müller, Marianne, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Kitaichi, Y., Inoue, T., Nakagawa, S., Boku, S., Izumi, T., & Koyama, T. (2010). Combined treatment with MAO-A inhibitor and MAO-B inhibitor increases extracellular noradrenaline levels more than MAO-A inhibitor alone through increases in beta-phenylethylamine. European Journal of Pharmacology, 637(1-3), 77-82.

Cite as: https://hdl.handle.net/11858/00-001M-0000-000E-9012-E

Abstract

There is no abstract available